Method for producing the purest rac1-{4-(2-hydroxy-3-(5-quinolyloxy)propyl) piperazin-1-yl}-2,2-diphenylethan-1-one fumarate and the purest rac1-{4-(2-hydroxy-3-(5-quinolyloxy)propyl) piperazin-1-yl}-2,2-diphenylethan-1-one fumarate

Details for Australian Patent Application No. 2004235898 (hide)

Owner Schering Aktiengesellschaft

Inventors Schneider, Matthias; Gottfried, Michael; Weinmann, Hilmar

Agent Davies Collison Cave

Pub. Number AU-A-2004235898

PCT Pub. Number WO2004/099151

Priority 103 21 255.8 06.05.03 DE

Filing date 22 April 2004

Wipo publication date 18 November 2004

International Classifications

C07D 215/20 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/099151 Priority application(s): WO2004/099151

18 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004235906-Affinity-based enrichment of phosphorylated peptides and/or proteins

2004235896-Twin roll casting plant